BNTX to Boost Oncology Pipeline With Biotheus Acquisition, …
14 hours ago · BioNTech SE BNTX announced that it has entered into a definitive agreement to acquire China-based biotech, ... Shares of BioNTech were up 4.9% on Nov. 13 following the announcement of the news ...
BioNTech SE (BNTX) Latest Stock News & Headlines - Yahoo …
Get the latest BioNTech SE (BNTX) stock news and headlines to help you in your trading and investing decisions.
BioNTech Acquires Biotheus to Enhance Cancer Therapies
2 days ago · Nov. 13, 2024, 06:19 AM. BioNTech SE (BNTX) has released an update. BioNTech SE is set to acquire Biotheus in a deal valued at $800 million, aiming to strengthen its oncology strategy by securing ...
BioNTech To Buy Biotheus In Upfront Payment Of $800 Mln
1 day ago · Nov. 13, 2024, 08:10 AM. (RTTNews) - BioNTech SE (BNTX) announced Tuesday that it has signed an agreement to acquire Biotheus, a clinical-stage biotechnology company focused on novel antibodies ...
BioNTech to Acquire Biotheus for $800 Million to Expand …
1 day ago · BNTX. BioNTech SE (BNTX, Financials) announced plans to acquire Biotheus, a clinical-stage biotechnology company, for $800 million, securing full global rights to BNT327/PM8002, an investigational ...
BioNTech to acquire Biotheus for upfront consideration of $800M
1 day ago · BioNTech (BNTX) and Biotheus announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of ...
BioNTech to Acquire Biotheus to Boost Oncology Strategy
1 day ago · Published. MAINZ, Germany, November 13, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today announced the signing of a definitive agreement for ...
BioNTech to Acquire Biotheus to Boost Oncology Strategy
1 day ago · BioNTech to Acquire Biotheus to Boost Oncology Strategy. MAINZ, Germany, November 13, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today ...
BioNTech Boosts Oncology Strategy With $800 Million+ China …
1 day ago · On Wednesday, BioNTech SE BNTX agreed to acquire Biotheus, a clinical-stage biotechnology company focused on discovering and developing antibodies for oncological or inflammatory diseases. With ...
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
Oct 26, 2023 · NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 …